Fertilizers · Founded 1997 · www.mbapl.com · NSE · ISIN INE900L01010
No Notes Added Yet
1. Business Overview
Madhya Bharat Agro Products Ltd. (MBAPL) operates in the Indian agricultural sector, primarily as a manufacturer and marketer of fertilizers. Its core business model revolves around producing essential plant nutrients and distributing them to farmers, likely through a network of dealers and retailers. The company makes money by selling its fertilizer products, which are crucial inputs for crop production, contributing to enhanced agricultural yields. As an agro-products company, it likely aims to serve the needs of the agricultural community in India.
2. Key Segments / Revenue Mix
Given its specified sector and industry, the primary and likely sole significant revenue segment for MBAPL is the production and sale of Fertilizers. This segment may include various types of fertilizers such as NPK complexes, Single Super Phosphate (SSP), or other nutrient formulations tailored for Indian soil conditions and crop requirements. Specific breakdown of fertilizer types or contribution to revenue is not available from the provided information.
3. Industry & Positioning
The Indian fertilizer industry is highly regulated, characterized by government subsidies, price controls, and significant reliance on imported raw materials (e.g., rock phosphate, ammonia, potash). It is a critical sector for food security, with a mix of large public sector undertakings, cooperatives, and private players. MBAPL, based on its typical structure for companies with "Agro Products" in their name and being a public listed entity, likely operates as a mid-sized to smaller regional or national player. It competes with larger, more established domestic manufacturers (e.g., Coromandel International, Chambal Fertilizers, RCF) as well as imported fertilizers, positioning itself by potentially focusing on specific regional markets or product niches.
4. Competitive Advantage (Moat)
Durable competitive advantages are generally challenging to establish in the commodity-driven fertilizer industry. MBAPL's potential advantages, though not strong moats, might include:
Distribution Network: A well-established distribution network, particularly in its key operating regions, could provide a logistical edge and farmer loyalty.
Cost Efficiency: Efficient manufacturing processes or favorable raw material sourcing could lead to a cost advantage.
Brand Recognition: While fertilizers are largely commodities, a trusted regional brand built on product quality and farmer relationships can offer some stability.
Overall, strong, durable moats like proprietary technology, high switching costs, or overwhelming scale are typically difficult to achieve for non-integrated players in this sector.
5. Growth Drivers
Agricultural Growth & Food Demand: Increasing population and the government's focus on boosting agricultural output in India drive demand for fertilizers.
Government Support: Favorable government policies, timely and adequate fertilizer subsidies, and initiatives to support farmers (e.g., minimum support price, irrigation projects) can stimulate demand.
Increased Fertilizer Consumption: Efforts to improve soil health and crop yields, coupled with limited arable land, necessitate higher and more efficient fertilizer application.
Product Innovation/Diversification: Introduction of specialty fertilizers, micronutrients, or organic variants could open new markets.
Geographic Expansion: Expanding market reach beyond current operational areas, if regionally focused.
6. Risks
Regulatory & Subsidy Risks: High dependence on government subsidies for affordability and profitability makes the company vulnerable to policy changes, delays in subsidy disbursement, and price controls.
Raw Material Price Volatility: Significant reliance on imported raw materials means profitability is highly sensitive to international price fluctuations and exchange rates.
Weather Dependency: Agricultural demand for fertilizers is directly linked to monsoons and other weather patterns; poor agricultural seasons can significantly reduce sales.
Competition: Intense competition from larger domestic players and imported products can pressure margins.
Environmental Regulations: Increasing environmental scrutiny and regulations on manufacturing processes could lead to higher compliance costs.
Working Capital Management: Delays in subsidy receipts often lead to high working capital requirements and potential liquidity issues.
7. Management & Ownership
Specific details regarding the promoters, management quality, or ownership structure of Madhya Bharat Agro Products Ltd. are not provided. However, similar to many Indian public companies, it is likely to be promoter-driven, often with significant family ownership. The quality of management would depend on their experience in the fertilizer sector, operational efficiency, financial prudence, and ability to navigate the complex regulatory environment and raw material volatility.
8. Outlook
Madhya Bharat Agro Products Ltd. operates in an essential but challenging sector. The fundamental demand for fertilizers is robust due to India's agricultural base and growing food requirements, offering a stable market foundation. Government support for agriculture and subsidies for fertilizers also provide a significant tailwind. However, the company faces inherent risks associated with a highly regulated, commodity-driven business, including reliance on unpredictable monsoons, volatile raw material prices, and the critical dependency on timely subsidy payments from the government. Its future performance will largely hinge on its operational efficiency, ability to manage working capital effectively, navigate regulatory changes, and potentially innovate or expand its product offerings within this competitive landscape.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 244 | 146 | 200 | 278 | 284 | 297 | 410 | 450 | 612 | 395 |
| Other Income | 0 | 9 | 2 | 2 | 2 | 6 | 3 | 2 | 3 | 9 |
| Total Income | 244 | 154 | 202 | 280 | 285 | 303 | 413 | 452 | 615 | 404 |
| Total Expenditure | 226 | 132 | 167 | 242 | 244 | 261 | 353 | 388 | 546 | 353 |
| Operating Profit | 18 | 23 | 35 | 38 | 41 | 42 | 60 | 64 | 69 | 50 |
| Interest | 4 | 8 | 9 | 7 | 5 | 7 | 7 | 6 | 9 | 11 |
| Depreciation | 7 | 7 | 9 | 9 | 9 | 8 | 9 | 9 | 9 | 9 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 7 | 8 | 18 | 23 | 27 | 27 | 44 | 49 | 51 | 31 |
| Provision for Tax | 5 | 6 | 6 | 9 | 9 | 13 | 16 | 18 | 19 | -29 |
| Profit After Tax | 1 | 1 | 11 | 14 | 18 | 14 | 28 | 30 | 32 | 60 |
| Adjustments | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | -0 | 0 |
| Profit After Adjustments | 1 | 1 | 11 | 14 | 18 | 14 | 28 | 30 | 32 | 60 |
| Adjusted Earnings Per Share | 0.1 | 0.2 | 1.3 | 1.6 | 2 | 1.6 | 3.2 | 3.5 | 3.6 | 6.8 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 62 | 65 | 82 | 90 | 116 | 131 | 186 | 491 | 982 | 817 | 1059 | 1867 |
| Other Income | 6 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 5 | 11 | 11 | 17 |
| Total Income | 68 | 65 | 86 | 90 | 116 | 131 | 186 | 492 | 987 | 828 | 1070 | 1884 |
| Total Expenditure | 56 | 52 | 60 | 69 | 87 | 96 | 144 | 385 | 772 | 721 | 914 | 1640 |
| Operating Profit | 13 | 12 | 25 | 21 | 30 | 35 | 42 | 107 | 215 | 108 | 157 | 243 |
| Interest | 3 | 3 | 5 | 5 | 4 | 3 | 4 | 8 | 16 | 26 | 28 | 33 |
| Depreciation | 3 | 4 | 7 | 8 | 10 | 10 | 9 | 18 | 22 | 29 | 34 | 36 |
| Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 6 | 6 | 13 | 7 | 16 | 21 | 29 | 81 | 176 | 52 | 95 | 175 |
| Provision for Tax | 2 | -3 | 2 | 2 | 4 | 7 | 8 | 24 | 52 | 27 | 37 | 24 |
| Profit After Tax | 4 | 9 | 12 | 5 | 11 | 15 | 20 | 57 | 124 | 25 | 57 | 150 |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit After Adjustments | 4 | 9 | 12 | 5 | 11 | 15 | 20 | 57 | 124 | 25 | 57 | 150 |
| Adjusted Earnings Per Share | 0.6 | 1.1 | 1.3 | 0.6 | 1.3 | 1.7 | 2.3 | 6.5 | 14.2 | 2.8 | 6.6 | 17.1 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | 30% | 29% | 52% | 33% |
| Operating Profit CAGR | 45% | 14% | 35% | 28% |
| PAT CAGR | 128% | 0% | 31% | 30% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | 86% | 23% | 92% | NA% |
| ROE Average | 15% | 23% | 23% | 17% |
| ROCE Average | 18% | 23% | 23% | 19% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 72 | 91 | 102 | 106 | 117 | 130 | 149 | 205 | 328 | 351 | 404 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 3 | 16 | 21 | 19 | 17 | 29 | 41 | 32 | 41 | 30 | 85 |
| Other Non-Current Liabilities | 3 | -1 | -3 | -2 | -1 | 2 | 5 | 15 | 56 | 73 | 106 |
| Total Current Liabilities | 16 | 6 | 26 | 28 | 26 | 28 | 68 | 186 | 317 | 351 | 351 |
| Total Liabilities | 94 | 112 | 146 | 151 | 159 | 189 | 264 | 439 | 743 | 804 | 946 |
| Fixed Assets | 59 | 88 | 94 | 102 | 93 | 83 | 85 | 153 | 203 | 265 | 279 |
| Other Non-Current Assets | 8 | 2 | 10 | 10 | 10 | 34 | 77 | 5 | 39 | 56 | 157 |
| Total Current Assets | 27 | 22 | 42 | 39 | 56 | 72 | 103 | 281 | 501 | 483 | 510 |
| Total Assets | 94 | 112 | 146 | 151 | 159 | 189 | 264 | 439 | 743 | 804 | 946 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 6 | 0 |
| Cash Flow from Operating Activities | 6 | 11 | 8 | 19 | 15 | 14 | 30 | -72 | -70 | 148 | 96 |
| Cash Flow from Investing Activities | -3 | -27 | -17 | -16 | -1 | -22 | -56 | -13 | -65 | -92 | -92 |
| Cash Flow from Financing Activities | -3 | 16 | 8 | -3 | -14 | 9 | 25 | 85 | 141 | -61 | -4 |
| Net Cash Inflow / Outflow | -1 | 0 | -0 | -0 | 0 | 1 | -1 | -0 | 6 | -6 | 0 |
| Closing Cash & Cash Equivalent | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 6 | 0 | 0 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.56 | 1.05 | 1.34 | 0.58 | 1.3 | 1.69 | 2.31 | 6.51 | 14.17 | 2.84 | 6.56 |
| CEPS(Rs) | 1.03 | 1.45 | 2.15 | 1.5 | 2.49 | 2.88 | 3.38 | 8.58 | 16.73 | 6.15 | 10.44 |
| DPS(Rs) | 0 | 0 | 0.5 | 0.5 | 0.5 | 0.13 | 0.13 | 0.13 | 0.25 | 0.5 | 0.5 |
| Book NAV/Share(Rs) | 6.49 | 7.61 | 8.81 | 9.28 | 13.33 | 14.88 | 17.05 | 23.43 | 37.48 | 40.05 | 46.09 |
| Core EBITDA Margin(%) | 10.19 | 18.73 | 25.94 | 22.81 | 25.42 | 26.53 | 22.4 | 21.69 | 21.36 | 11.77 | 13.73 |
| EBIT Margin(%) | 14.64 | 13.47 | 22.37 | 13.87 | 16.7 | 18.75 | 17.43 | 18.05 | 19.61 | 9.61 | 11.59 |
| Pre Tax Margin(%) | 9.43 | 9.12 | 16.14 | 8.09 | 13.57 | 16.4 | 15.39 | 16.52 | 17.94 | 6.4 | 8.93 |
| PAT Margin (%) | 6.47 | 14.17 | 14.28 | 5.68 | 9.85 | 11.34 | 10.9 | 11.6 | 12.65 | 3.04 | 5.43 |
| Cash Profit Margin (%) | 11.94 | 19.61 | 22.92 | 14.65 | 18.8 | 19.29 | 15.95 | 15.29 | 14.93 | 6.59 | 8.64 |
| ROA(%) | 4.44 | 8.96 | 9.09 | 3.44 | 7.39 | 8.54 | 8.93 | 16.21 | 21.02 | 3.21 | 6.57 |
| ROE(%) | 8.89 | 16.2 | 16.3 | 6.45 | 11.54 | 12.01 | 14.47 | 32.15 | 46.54 | 7.31 | 15.23 |
| ROCE(%) | 16.7 | 12.47 | 18.83 | 10.96 | 14.9 | 15.66 | 16.61 | 30.15 | 37.77 | 12.16 | 18.02 |
| Receivable days | 19.32 | 35.64 | 43.78 | 49.59 | 53.46 | 69.77 | 54.11 | 37.54 | 50.72 | 85.99 | 76.17 |
| Inventory Days | 61.21 | 41.25 | 52.07 | 65.03 | 55.59 | 75.13 | 84.57 | 78.19 | 69.03 | 94.05 | 64.45 |
| Payable days | 39.01 | 43.1 | 49.76 | 54.52 | 39.52 | 34.9 | 55.48 | 36.66 | 14.72 | 24.9 | 39.48 |
| PER(x) | 0 | 0 | 9.54 | 18.42 | 10.73 | 9.71 | 10.69 | 15.55 | 20.05 | 85.09 | 42.83 |
| Price/Book(x) | 0 | 0 | 1.45 | 1.16 | 1.05 | 1.1 | 1.45 | 4.32 | 7.58 | 6.02 | 6.1 |
| Dividend Yield(%) | 0 | 0 | 0.98 | 1.16 | 0.89 | 0.76 | 0.51 | 0.12 | 0.09 | 0.21 | 0.18 |
| EV/Net Sales(x) | 0.43 | 0.6 | 1.78 | 1.44 | 1.28 | 1.4 | 1.54 | 2.12 | 2.84 | 2.93 | 2.61 |
| EV/Core EBITDA(x) | 2.12 | 3.18 | 5.71 | 6.32 | 5 | 5.24 | 6.86 | 9.75 | 12.98 | 22.24 | 17.66 |
| Net Sales Growth(%) | 5.83 | 3.91 | 26.24 | 10.15 | 29.07 | 12.76 | 41.91 | 164.65 | 99.81 | -16.81 | 29.65 |
| EBIT Growth(%) | 5.52 | -4.32 | 109.92 | -32.07 | 55.22 | 26.6 | 31.98 | 174.02 | 117.09 | -59.24 | 56.3 |
| PAT Growth(%) | 12.29 | 127.89 | 27.39 | -56.4 | 123.55 | 29.78 | 36.42 | 181.69 | 117.82 | -80 | 131.34 |
| EPS Growth(%) | 12.27 | 88.4 | 27.39 | -56.4 | 123.55 | 29.78 | 36.43 | 181.7 | 117.82 | -80 | 131.34 |
| Debt/Equity(x) | 0.19 | 0.27 | 0.43 | 0.44 | 0.23 | 0.31 | 0.47 | 0.8 | 0.98 | 0.83 | 0.79 |
| Current Ratio(x) | 1.71 | 3.82 | 1.64 | 1.41 | 2.19 | 2.62 | 1.5 | 1.51 | 1.58 | 1.38 | 1.45 |
| Quick Ratio(x) | 1.14 | 2.79 | 0.96 | 0.88 | 1.37 | 1.42 | 0.72 | 0.66 | 0.91 | 0.79 | 0.98 |
| Interest Cover(x) | 2.81 | 3.1 | 3.59 | 2.4 | 5.35 | 8 | 8.52 | 11.77 | 11.72 | 2.99 | 4.37 |
| Total Debt/Mcap(x) | 0 | 0 | 0.3 | 0.38 | 0.21 | 0.28 | 0.32 | 0.18 | 0.13 | 0.14 | 0.13 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.54 | 74.52 | 74.43 | 74.53 | 74.56 | 74.56 | 74.56 | 74.63 | 74.76 | 74.76 |
| FII | 0 | 0 | 0 | 0 | 0 | 0.03 | 0.11 | 0.43 | 0.19 | 0.46 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 25.46 | 25.48 | 25.57 | 25.47 | 25.44 | 25.41 | 25.34 | 24.95 | 25.06 | 24.78 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 6.53 | 6.53 | 6.52 | 6.53 | 6.53 | 6.53 | 6.53 | 6.54 | 6.55 | 6.55 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.04 | 0.02 | 0.04 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 2.23 | 2.23 | 2.24 | 2.23 | 2.23 | 2.23 | 2.22 | 2.19 | 2.2 | 2.17 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8.76 | 8.76 | 8.76 | 8.76 | 8.76 | 8.76 | 8.76 | 8.76 | 8.76 | 8.76 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 74.54 | 74.52 | 74.43 | 74.53 | 74.56 | 74.56 | 74.56 | 74.63 | 74.76 | 74.76 |
| FII | 0 | 0 | 0 | 0 | 0 | 0.03 | 0.11 | 0.43 | 0.19 | 0.46 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 25.46 | 25.48 | 25.57 | 25.47 | 25.44 | 25.44 | 25.44 | 25.37 | 25.24 | 25.24 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 6.53 | 6.53 | 6.52 | 6.53 | 6.53 | 6.53 | 6.53 | 6.54 | 6.55 | 6.55 |
| FII | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.04 | 0.02 | 0.04 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 2.23 | 2.23 | 2.24 | 2.23 | 2.23 | 2.23 | 2.23 | 2.22 | 2.21 | 2.21 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8.76 | 8.76 | 8.76 | 8.76 | 8.76 | 8.76 | 8.76 | 8.76 | 8.76 | 8.76 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | +30% | +29% | +52% | +33% |
| Operating Profit CAGR | +45% | +14% | +35% | +28% |
| PAT CAGR | +128% | 0% | +31% | +30% |
| Share Price CAGR | +86% | +23% | +92% | — |
| ROE Average | +15% | +23% | +23% | +17% |
| ROCE Average | +18% | +23% | +23% | +19% |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.